Results 241 to 250 of about 77,075 (344)

Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview

Thoracic Cancer, Volume 17, Issue 8, April 2026.
This review examines pleural mesothelioma, from risk factors and pathogenesis to diagnostic approaches and histological classification. We discuss current treatment strategies including chemotherapy and FDA‐approved immunotherapy, alongside emerging therapies such as VISTA, LAG‐3 inhibitors, and dendritic cell‐based approaches for personalized ...
Raffaella Pagliaro, Beatrice Leonardi, Angela Schiattarella, Grazia Bergameo, Carmine Picone, Adolfo Gallipoli D'Errico, Filippo Scialò, Fabio Perrotta, Maria Luisa De Rimini, Alfonso Fiorelli, Andrea Bianco   +10 more
wiley   +1 more source

Case Report: Ivonescimab in EGFR-mutant lung cancer with baseline malignant pleural effusion and acquired complex resistance. [PDF]

Front Immunol
Mo Z, Jiang H, Zhou L, Ren Q, Shen G, Li L, Jian X, Yang H, Bai Y, Meng M, He S.   +10 more
europepmc   +1 more source

Malignant pleural effusion

Palliative Medicine, 2019
openaire   +1 more source

Pleural‐Based GLI1‐Altered Mesenchymal Tumor With ACTB‐GLI1 Fusion: A Rare Pulmonary Entity Mimicking Synovial Sarcoma

Thoracic Cancer, Volume 17, Issue 7, April 2026.
Pleural‐based GLI1‐altered mesenchymal tumor presenting as an incidental thoracic mass, characterized by biphasic morphology and ACTB‐GLI1 fusion, managed by thoracoscopic resection and surveillance. ABSTRACT GLI1‐altered mesenchymal tumors are exceptionally rare mesenchymal tumors, with recent molecular studies implicating GLI1 gene fusion or ...
Marco Lizwan, Li Xiao, Chun Yuen Chow, Hiu Yeung Lau, Boon‐Hean Ong   +4 more
wiley   +1 more source

Outcome of Management of Malignant Pleural Effusion by Tube Thoracostomy and Chemical Pleurodesis - Study of 282 Cases

, 2013
MS Rahman, MN Uddin, MA Islam, M. M. Rahman, MNI Majumdar   +4 more
openalex   +2 more sources

Effects of light's criteria on the diagnostic accuracy of pleural fluid carcinoembryonic antigen concentrations for malignant pleural effusion. [PDF]

Sci Rep
Yang DN, Xu YN, Niu Y, Wen JX, Yan L, Jiao W, Zheng WQ, Jiang TW, Hu ZD.   +8 more
europepmc   +1 more source

Safety and Efficacy Assessment of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2‐Positive Unresectable Locally Advanced or Metastatic Breast Cancer Previously Treated With Trastuzumab and a Taxane: An Open‐Label, Single‐Arm, Phase IV Study

Asia-Pacific Journal of Clinical Oncology, Volume 22, Issue 2, Page 240-250, April 2026.
A phase IV, single‐arm, open‐label, multicenter study assessing the safety and efficacy of trastuzumab emtansine in Indian patients for the treatment of human epidermal growth factor receptor 2 (HER2)‐positive unresectable locally advanced or metastatic breast cancer who received prior treatment with trastuzumab and a taxane.
Sudeep Gupta, Manish Singhal, Shona Nag, Waseem Abbas, Dinesh Chandra Doval, Hari Goyal, Chirag Shah, Ashish Singh, Radheshyam Naik, Nitesh Rohatgi, Poonam Patil, Shyam Aggarwal, Vinod Raina, Vaibhav Watts   +13 more
wiley   +1 more source

Malignant pleural effusion. [PDF]

British medical journal, 1968
openaire   +3 more sources

Visible-Light Hyperspectral Reconstruction and PCA-Based Feature Extraction for Malignant Pleural Effusion Cytology. [PDF]

Biosensors (Basel)
Lai CL, Lee KH, Nguyen HT, Mukundan A, Karmakar R, Chen TH, Lin WS, Wang HC.   +7 more
europepmc   +1 more source

Cancer‐Specific Antihuman Podoplanin Antibody chLpMab‐2f Exerts Antitumor Effects Against Pleural Mesothelioma

Cancer Science, Volume 117, Issue 4, Page 917-928, April 2026.
Cancer‐specific antihuman podoplanin antibody chLpMab‐2f exerted antibody‐dependent cellular cytotoxicity and complement‐dependent cytotoxicity against pleural mesothelioma (PM) cell lines. Additionally, chLpMab‐2f inhibited tumor progression in mice with subcutaneously and intrathoracically transplanted human PM cells.
Aito Yoshida, Shinji Abe, Toshihiro Izumi, Satoshi Itakura, Keichiro Yamada, Takuya Wada, Takaaki Yamamoto, Chiemi Sato, Atsushi Mitsuhashi, Hirokazu Ogino, Seidai Sato, Tsutomu Shinohara, Masaki Hanibuchi, Mika K. Kaneko, Yukinari Kato, Yasuhiko Nishioka   +15 more
wiley   +1 more source